About 90% of the active ingredients used by US companies in drug manufacturing come from China. That’s been the case for a number of years, but the coronavirus outbreak has put that dependence under scrutiny. Congress is now taking up the issue as pharmacies and hospitals brace for shortages because of disrupted production in China. Marco Werman talks with Rosemary Gibson, author of “China RX: Exposing the Risks of America’s Dependence on China for Medicine.”
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?